AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Medrok G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Abdach Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Medrok G 1mg/500mg Tablet SR

Diabetex Duo 1mg/500mg Extended-Release Tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan; a healthy diet, regular physical activity, and weight management, as directed by your doctor, are essential. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are vital to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Medrok G 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Medrok G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Medrok G 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this medication with food.

Common Side effects of Medrok G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Medrok G 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Medrok G 1mg/500mg Extended-Release Tablet with a meal.

How Medrok G 1mg/500mg Tablet SR works:

Medrok G SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Medrok G 1mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Medrok G 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Medrok G tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Medrok G 1mg/500mg Tablet SR, potentially requiring dosage modification. A physician's consultation is advised. Medrok G 1mg/500mg Tablet SR is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Medrok G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Medrok G 1mg/500mg Tablet SR :

Should you forget a Medrok G 1mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Medrok G 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Medrok G 1mg/500mg Tablet SR

Store the medication in its original, tightly sealed container or packaging. Follow the storage guidelines provided on the label or packaging. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Medrok G 1mg/500mg Tablet SR can induce lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this infrequent adverse reaction is a significant risk for individuals with impaired kidney function, the elderly, or those consuming substantial alcohol. Symptoms potentially include muscular aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. The appearance of these symptoms necessitates immediate discontinuation of Medrok G 1mg/500mg Tablet SR and prompt medical attention.
Glimepiride/Metformin (Medrok G 1mg/500mg SR) is a dual-action tablet indicated for adult patients with type 2 diabetes. This medication combines glimepiride, which stimulates pancreatic insulin release, and metformin, which reduces hepatic glucose production and enhances insulin responsiveness. Effective blood glucose control requires concurrent dietary management and physical activity. This formulation is unsuitable for individuals with type 1 diabetes.
Medrok G 1mg/500mg Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged administration can result in vitamin B12 deficiency.
Medrok G 1mg/500mg SR tablets can induce Vitamin B12 deficiency with prolonged administration due to impaired Vitamin B12 absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may lead to anemia, neurological complications including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic annual Vitamin B12 supplementation is recommended by some investigators to mitigate these risks.
Medrok G 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice at all times.
Consuming Medrok G 1mg/500mg Tablet SR concurrently with alcohol is unsafe. This combination may cause a drop in blood glucose, resulting in hypoglycemia, and heighten the risk of lactic acidosis.
Medrok G 1mg/500mg Tablet...
45
MRP 55
18% off